Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China

Haematologica. 2022 Aug 1;107(8):1966-1970. doi: 10.3324/haematol.2022.280637.
No abstract available

MeSH terms

  • China
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Protein Kinase Inhibitors / therapeutic use
  • Retrospective Studies

Substances

  • Protein Kinase Inhibitors
  • Imatinib Mesylate